Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. / Le Noury, Joanna; Nardo, John M.; Healy, David et al.
Yn: International Journal of Risk & Safety in Medicine, Cyfrol 28, Rhif 3, 17.09.2016, t. 143-161.
Yn: International Journal of Risk & Safety in Medicine, Cyfrol 28, Rhif 3, 17.09.2016, t. 143-161.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Le Noury, J, Nardo, JM, Healy, D, Jureidini, J, Raven, M, Tufanaru, C & Abi-Jaoude, E 2016, 'Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression', International Journal of Risk & Safety in Medicine, cyfrol. 28, rhif 3, tt. 143-161. https://doi.org/10.3233/JRS-160728
APA
Le Noury, J., Nardo, J. M., Healy, D., Jureidini, J., Raven, M., Tufanaru, C., & Abi-Jaoude, E. (2016). Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. International Journal of Risk & Safety in Medicine, 28(3), 143-161. https://doi.org/10.3233/JRS-160728
CBE
Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E. 2016. Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. International Journal of Risk & Safety in Medicine. 28(3):143-161. https://doi.org/10.3233/JRS-160728
MLA
Le Noury, Joanna et al. "Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression". International Journal of Risk & Safety in Medicine. 2016, 28(3). 143-161. https://doi.org/10.3233/JRS-160728
VancouverVancouver
Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C et al. Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. International Journal of Risk & Safety in Medicine. 2016 Medi 17;28(3):143-161. doi: 10.3233/JRS-160728
Author
RIS
TY - JOUR
T1 - Study 329 continuation phase
T2 - Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression
AU - Le Noury, Joanna
AU - Nardo, John M.
AU - Healy, David
AU - Jureidini, Jon
AU - Raven, Melissa
AU - Tufanaru, Catalin
AU - Abi-Jaoude, Elia
PY - 2016/9/17
Y1 - 2016/9/17
U2 - 10.3233/JRS-160728
DO - 10.3233/JRS-160728
M3 - Article
VL - 28
SP - 143
EP - 161
JO - International Journal of Risk & Safety in Medicine
JF - International Journal of Risk & Safety in Medicine
SN - 0924-6479
IS - 3
ER -